论文部分内容阅读
目的:观察舒氨新对急性淋巴细胞性白血病继发感染的疗效。方法:治疗组30例,每日用舒氨新4～6g,分2次静脉滴注;对照组20例,每日用氨苄西林8g,1次静脉滴注。结果:舒氨新治疗有效率明显高于氨苄西林。结论:舒氨新能有效地控制白血病患者的继发感染。
Objective: To observe the curative effect of Shu-Axin on secondary infection of acute lymphocytic leukemia. Methods: Thirty patients in the treatment group were treated with Shuyangxin 4~6g daily and intravenously in 2 groups. In the control group, 20 patients were treated with ampicillin 8g once daily and intravenously. RESULTS: The effective rate of Shu-Axin was significantly higher than that of ampicillin. Conclusion: Shu ammoniaxin can effectively control the secondary infection of leukemia patients.